Directorate Change

Friday, 22 October 2010, 14:00 BST

Press Release

                          Colin Day, CFO, to leave RB                          

Reckitt Benckiser (RB) announces that Colin Day, chief financial officer and
executive member of the Board will leave the company. His successor will be
announced in the next few months.

Effective succession management is an important business principle in RB. Colin
wants to focus increasingly on his portfolio of non-executive positions and
other career interests, and the Board has decided that now is a good time to
appoint a successor keen to focus on leading the company's finance function in
support of the next stage of RB's growth.

Bart Becht, CEO, Adrian Bellamy, Chairman, and the rest of the Board want to
thank Colin for his 10 years as chief financial officer (CFO). During his
tenure he has made a significant contribution to the performance of the
business. Our appreciation is in particular for ensuring strong financial
management and control, overseeing excellent cash generation and working with
the leadership team on a number of key strategic acquisitions. He hands across
a baton of a company in a strong financial position for someone else to now
take forward.

To ensure a smooth transition and an effective handover Colin will remain with
the business until end of March 2011.

                                     ENDS                                      

Enquiries:

Investor and analyst enquiries:

Jo Speed, RB, Investor Relations Director, [phone]

Media enquiries:

Andraea Dawson-Shepherd, RB, [phone]

David Litterick/Teresa Bianchi, Brunswick [phone]



About Reckitt Benckiser

Reckitt Benckiser (RB) is a world leader in household, health and personal
care.

It is a FTSE top 25 company and since 2000 net revenues have doubled and the
market cap has quadrupled. Today it is the global No 1 or No 2 in the majority
of its fast-growing categories, driven by an exceptional rate of innovation -
typically about 35% of net revenue comes from innovations launched in the prior
3 years. It has a strong portfolio led by 17 global powerbrands which are:
Finish, Lysol, Dettol, Vanish, Woolite, Calgon, Airwick, Harpic, Bang, Mortein,
Veet, Nurofen, Clearasil, Strepsils Gaviscon, Mucinex and French's, and they
account for 70% of net revenue.

RB people are at the heart of the company's success. They have an intense drive
for progress and action and a desire to outperform wherever they focus,
including in CSR where the company has the most ambitious corporate
responsibility programme in the industry through its Carbon 20 initiative.

Headquartered in the United Kingdom, the company employs 24,900 people
worldwide, with operations in over 60 countries and sales in almost 200
countries.

For more information visit RB.COM